THE EFFECT OF GUSELKUMAB INDUCTION THERAPY ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: QUASAR PHASE 2B INDUCTION RESULTS THROUGH WEEK 12

Laurent Peyrin-Biroulet  1     Axel Dignass  2     William Sandborn  3     Kuan-Hsiang G. Huang  4     Matthew Germinaro  4     Rebbecca Wilson  4     Hongyan Zhang  4     Baili CHEN  5     Minhu Chen  5     Tadakazu Hisamatsu  6     Brian G. Feagan  7     Julian Panés  8     Gary Lichtenstein  9    
1 Nancy University Hospital, Vandoeuvre-les-Nancy, France
2 Agaplesion Markus Krankenhaus, Frankfurt/ Main, Germany
3 University of California San Diego, San Diego, United States
4 Janssen Research & Development, LLC, Spring House
5 The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
6 Kyorin University, Tokyo, Japan
7 Alimentiv Inc., London, Canada
8 Hospital Clínic Barcelona, Barcelona, Spain
9 University of Pennsylvania School of Medicine, Merion Station, United States

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing